How to use cerebral vasodilators and metabolic activators.
Cerebral vasodilators and metabolic activators (enhancers) for the treatment of cerebrovascular disorders (CVD) have been categorized and introduced into clinical practice according to their pharmacological actions and clinical indications. The main therapeutic goal of these drugs is to relieve residual subjective symptoms and neuropsychological dysfunction, which reduce the quality of life of patients in the chronic stage of stroke. Selection of the most suitable drug for the individual symptoms of each patient is an important therapeutic principle.
Isozumi
K
K
Department of Neurology, Ashikaga Red Cross Hospital, Tochigi, Japan.
Izumi
Y
Y
D001711:Biotransformation; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008660:Metabolism / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002491:Central Nervous System Agents; D014665:Vasodilator Agents